Does lipoprotein(a) impair endothelial function?

Department of Medicine IV/Nephrology, University of Erlangen-Nuremberg, Nuremberg, Germany.

OBJECTIVES: This study was undertaken to test the hypothesis that lipoprotein(a) [Lp(a)] impairs endothelial function. BACKGROUND: Elevated Lp(a) plasma levels have been demonstrated to be associated with an increased risk of coronary heart disease. In atherosclerosis, endothelial dysfunction is known to be an early indicator of vascular changes. However, the effect of Lp(a) on nitric oxide (NO)-dependent vasodilator response has not yet been determined. We therefore examined the influence of Lp(a) on basal and stimulated NO-mediated vasodilator response in the forearm vascular bed. METHODS: Strain gauge plethysmography was used to measure changes in forearm blood flow produced by intraarterial infusion of increasing doses of acetylcholine (3, 12, 24 and 48 microg/min), sodium nitroprusside (200, 800 and 3,200 ng/min) and N-monomethyl L-arginine (L-NMMA) (1, 2 and 4 micromol/min) in 57 white subjects (mean age +/- SD 37 +/- 14 years). Lp(a) plasma concentrations were determined by rocket immunoelectrophoresis. RESULTS: Endothelium-dependent vasodilation tested by intraarterial acetylcholine and endothelium-independent vascular relaxation tested by intraarterial sodium nitroprusside were not correlated with Lp(a). Similarly, no significant differences in forearm blood flow changes were observed when patients were classified into tertiles according to their individual Lp(a) concentration. In contrast, changes in forearm blood flow after intraarterial L-NMMA indicating basal production and release of NO differed significantly among tertiles. Patients in the highest Lp(a) tertile (49.2 +/- 20.3 mg/dl) had a much greater vasoconstrictive response to L-NMMA than patients in the lowest Lp(a) tertile (4.8 +/- 2.5 mg/dl): 2 micromol/min of L-NMMA, -23.6 +/- 22.5% vs. -10.4 +/- 9.1% (p < 0.02); 4 micromol/min of L-NMMA, -27.8 +/- 10.3% vs. -17.6 +/- 9.9% (p < 0.03). Lp(a) plasma level consistently correlated negatively with the forearm blood flow responses to 4 micromol/min of intraarterial L-NMMA (r = -0.38, p < 0.01). Multiple stepwise regression analysis of variables, including total and high and low density lipoprotein cholesterol, further confirmed that plasma Lp(a) remained a significant independent determinant of forearm blood flow changes in response to L-NMMA (p < 0.02). CONCLUSIONS: The endothelium-dependent vasoconstrictive response to L-NMMA was enhanced in subjects with relatively high Lp(a) plasma levels, suggesting an increased basal production and release of NO. This response seemed to reflect a compensatory mechanism of the endothelium to yet unknown Lp(a)-induced atherosclerotic effects.

This article has been cited by other articles:

				M. Kivimaki, C. G. Magnussen, M. Juonala, M. Kahonen, J. Kettunen, B.-M. Loo, T. Lehtimaki, J. Viikari, and O. T. Raitakari Conventional and Mendelian randomization analyses suggest no association between lipoprotein(a) and early atherosclerosis: the Young Finns Study Int. J. Epidemiol., April 1, 2011; 40(2): 470 - 478. [Abstract] [Full Text] [PDF]

				J. C. Hopewell, R. Clarke, S. Parish, J. Armitage, M. Lathrop, J. Hager, R. Collins, and on behalf of the Heart Protection Study Collaborat Lipoprotein(a) Genetic Variants Associated With Coronary and Peripheral Vascular Disease but Not With Stroke Risk in the Heart Protection Study Circ Cardiovasc Genet, February 1, 2011; 4(1): 68 - 73. [Abstract] [Full Text] [PDF]

				Z. G. Ozturk, H. Ekmekci, O. B. Ekmekci, P. Atukeren, I. Butun, S. Gode, K. Besirli, E. Kokoglu, and H. Sonmez Nontraditional Risk Factors in Carotid Artery Disease Clinical and Applied Thrombosis/Hemostasis, October 1, 2010; 16(5): 554 - 558. [Abstract] [PDF]

				M. B. Lanktree, S. S. Anand, S. Yusuf, R. A. Hegele, and on behalf of the SHARE Investigators Comprehensive Analysis of Genomic Variation in the LPA Locus and Its Relationship to Plasma Lipoprotein(a) in South Asians, Chinese, and European Caucasians Circ Cardiovasc Genet, February 1, 2010; 3(1): 39 - 46. [Abstract] [Full Text] [PDF]

				M. B. Lanktree, C. Rajakumar, J. H. Brunt, M. L. Koschinsky, P. W. Connelly, and R. A. Hegele Determination of lipoprotein(a) kringle repeat number from genomic DNA: copy number variation genotyping using qPCR J. Lipid Res., April 1, 2009; 50(4): 768 - 772. [Abstract] [Full Text] [PDF]

				D Tousoulis, C Antoniades, and C Stefanadis Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques Heart, April 1, 2005; 91(4): 553 - 558. [Full Text] [PDF]

				J. Davignon and P. Ganz Role of Endothelial Dysfunction in Atherosclerosis Circulation, June 15, 2004; 109(23_suppl_1): III-27 - III-32. [Abstract] [Full Text]

				A. Prasad, S. Narayanan, M. A. Waclawiw, N. Epstein, and A. A. Quyyumi The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1579 - 1586. [Abstract] [Full Text] [PDF]

				A. M Dart and J. P.F Chin-Dusting Lipids and the endothelium Cardiovasc Res, August 1, 1999; 43(2): 308 - 322. [Abstract] [Full Text] [PDF]

				O. T. Raitakari, M. R. Adams, and D. S. Celermajer Effect of Lp(a) on the Early Functional and Structural Changes of Atherosclerosis Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 990 - 995. [Abstract] [Full Text] [PDF]